Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Blum

Showing results (231-240 of 336) with videos related to

Pageof 34
Sort By:
Journal of Systems and Integrative Neuroscience|September 11, 2018
"Dopamine homeostasis" requires balanced polypharmacy: Issue with destructive, powerful dopamine agents to combat America's drug epidemicKenneth Blum, Edward J Modestino, Marjorie Gondré-Lewis, et al.
Current Neuropharmacology|June 23, 2026
Tobacco and Nicotine Dependence Vulnerability as a Function of Dopaminergic Dysregulation: Proposing a Novel Strategy to Promote Neurotransmitter HomeostasisKenneth Blum, Kai Uwe Lewandrowski, Morgan P Lorio, et al.
Genes|September 29, 2017
BARHL1 Is Downregulated in Alzheimer's Disease and May Regulate Cognitive Functions through ESR1 and Multiple PathwaysDebmalya Barh, María E García-Solano, Sandeep Tiwari, et al.
Psychology Research and Behavior Management|February 6, 2025
Coupling Bio-Resonance Neurotechnology (BRNT) and Dual Hemispheric Repetitive Transcranial Magnetic Stimulation (rTMS) Reduces Comorbid Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD) as Demonstrated by PHQ-9 and GAD-7: Pilot Case SeriesKeerthy Sunder, Milan T Makale, Miles Makale, et al.
Journal of Addiction Psychiatry|August 10, 2023
Psychostimulants for Children: Are We Over or Under Dosing?Kenneth Blum, Catherine Dennen, Paul R Carney, et al.
Journal of Addiction Science|May 21, 2020
Addiction by Any Other Name is Still Addiction: Embracing Molecular Neurogenetic/Epigenetic Basis of Reward DeficiencyDrew Edwards, A Kenison Roy, Brent Boyett, et al.
Cases Journal|February 26, 2010
Healing enhancement of chronic venous stasis ulcers utilizing H-WAVE(R) device therapy: a case seriesKenneth Blum, Amanda Lh Chen, Thomas Jh Chen, et al.
Journal of Reward Deficiency Syndrome|August 26, 2015
The Molecular Neurobiology of Twelve Steps Program & Fellowship: Connecting the Dots for RecoveryKenneth Blum, Benjamin Thompson, Zsolt Demotrovics, et al.
Journal of Child and Adolescent Psychopharmacology|April 29, 2015
Neurogenetic and epigenetic correlates of adolescent predisposition to and risk for addictive behaviors as a function of prefrontal cortex dysregulationKenneth Blum, Marcelo Febo, David E Smith, et al.
Age (Dordrecht, Netherlands)|May 9, 2009
Plasma growth hormones, P300 event-related potential and test of variables of attention (TOVA) are important neuroendocrinological predictors of early cognitive decline in a clinical setting: evidence supported by structural equation modeling (SEM) parameter estimatesEric R Braverman, Thomas J H Chen, Thomas J Prihoda, et al.
Pageof 34

Showing results (231-240 of 336) with videos related to

Sort By:
Pageof 34
Journal of Systems and Integrative Neuroscience|September 11, 2018
"Dopamine homeostasis" requires balanced polypharmacy: Issue with destructive, powerful dopamine agents to combat America's drug epidemicKenneth Blum, Edward J Modestino, Marjorie Gondré-Lewis, et al.
Current Neuropharmacology|June 23, 2026
Tobacco and Nicotine Dependence Vulnerability as a Function of Dopaminergic Dysregulation: Proposing a Novel Strategy to Promote Neurotransmitter HomeostasisKenneth Blum, Kai Uwe Lewandrowski, Morgan P Lorio, et al.
Genes|September 29, 2017
BARHL1 Is Downregulated in Alzheimer's Disease and May Regulate Cognitive Functions through ESR1 and Multiple PathwaysDebmalya Barh, María E García-Solano, Sandeep Tiwari, et al.
Psychology Research and Behavior Management|February 6, 2025
Coupling Bio-Resonance Neurotechnology (BRNT) and Dual Hemispheric Repetitive Transcranial Magnetic Stimulation (rTMS) Reduces Comorbid Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD) as Demonstrated by PHQ-9 and GAD-7: Pilot Case SeriesKeerthy Sunder, Milan T Makale, Miles Makale, et al.
Journal of Addiction Psychiatry|August 10, 2023
Psychostimulants for Children: Are We Over or Under Dosing?Kenneth Blum, Catherine Dennen, Paul R Carney, et al.
Journal of Addiction Science|May 21, 2020
Addiction by Any Other Name is Still Addiction: Embracing Molecular Neurogenetic/Epigenetic Basis of Reward DeficiencyDrew Edwards, A Kenison Roy, Brent Boyett, et al.
Cases Journal|February 26, 2010
Healing enhancement of chronic venous stasis ulcers utilizing H-WAVE(R) device therapy: a case seriesKenneth Blum, Amanda Lh Chen, Thomas Jh Chen, et al.
Journal of Reward Deficiency Syndrome|August 26, 2015
The Molecular Neurobiology of Twelve Steps Program & Fellowship: Connecting the Dots for RecoveryKenneth Blum, Benjamin Thompson, Zsolt Demotrovics, et al.
Journal of Child and Adolescent Psychopharmacology|April 29, 2015
Neurogenetic and epigenetic correlates of adolescent predisposition to and risk for addictive behaviors as a function of prefrontal cortex dysregulationKenneth Blum, Marcelo Febo, David E Smith, et al.
Age (Dordrecht, Netherlands)|May 9, 2009
Plasma growth hormones, P300 event-related potential and test of variables of attention (TOVA) are important neuroendocrinological predictors of early cognitive decline in a clinical setting: evidence supported by structural equation modeling (SEM) parameter estimatesEric R Braverman, Thomas J H Chen, Thomas J Prihoda, et al.
Pageof 34